CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Newron Pharmaceuticals Spa Company Snapshot
Newron Pharmaceuticals Spa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other miscellaneous service companies in Europe: Sprint Bioscience AB of Sweden (2016 sales of 34.99 million Swedish Kronor [US$3.98 million] ), Genedrive PLC of the United Kingdom (£5.06 million [US$6.32 million] of which 40% was Preclinical Research services), and IXICO PLC which is also based in the United Kingdom (£3.11 million [US$3.88 million] of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Newron Pharmaceuticals Spa were 4.74 million Euro (US$5.12 million). This is an increase of 108.2% versus 2015, when the company's sales were 2.28 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Newron Pharmaceuticals Spa
  Stock Performance Chart for Newron Pharmaceuticals Spa
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 22.45
(Figures in Euro)
1 Week -9.1%   13 Weeks 9.1%  
4 Weeks 17.0%   52 Weeks 7.2%  
 
Newron Pharmaceuticals Spa Key Data:
  Ticker: NWRN Country: Italy
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 4,737,000
(Year Ending Jan 2017).
Employees: 1
  Currency: Euro Market Cap: 354,106,044
  Fiscal Yr Ends: December Shares Outstanding: 15,773,168
  Share Type: Azioni Ordinaire Closely Held Shares: 4,221,030
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.